BIOVIC B
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Biovica International is a pharmaceutical company that focuses its research on cancer treatment. The company develops blood-based biomarker tests to monitor and evaluate cancer treatments. The tests analyze the risk of developing the enzyme thymidine kinase, an enzyme that is linked to tumor growth. The main focus is on the treatment of breast cancer. Biovica International was founded in 2008 and is headquartered in Uppsala.
Lue lisääLiikevaihto milj.
EBIT-% (oik.)
EPS (oik.)
Osinko %
Vuosikatsaus '26
Osavuosikatsaus Q1'27
Yhtiökokous '26
Älä jää mistään paitsi – luo käyttäjätunnus ja ota kaikki hyödyt irti Inderesin palvelusta.
